Page 445«..1020..444445446447..450460..»

Creative Medical Technology Stock Price Increased 80.77%: Why It Happened – Pulse 2.0

Posted: Published on December 18th, 2020

The stock price of Creative Medical Technology Holdings Inc (OTCMKTS: CELZ) a company that engages in stem cell research and developing applications to treat male sexual dysfunction and related issues increased by 80.77% yesterday as it went from $0.0026 to $0.0047 per share. One of the biggest triggers for the stock price increase is an announcement about the company announcing the successful application of ImmCelz immunotherapy for treatment of stroke Continue reading

Posted in Stem Cell Research | Comments Off on Creative Medical Technology Stock Price Increased 80.77%: Why It Happened – Pulse 2.0

Global Cell Therapy Market Report 2020: Market is Expected to Decline from $7.31 Billion in 2019 to $7.2 Billion in 2020 at a CAGR of -1.54% -…

Posted: Published on December 18th, 2020

December 17, 2020 06:13 ET | Source: Research and Markets Dublin, Dec. 17, 2020 (GLOBE NEWSWIRE) -- The "Cell Therapy Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. Cell Therapy Global Market Report 2020-30: COVID 19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global cell therapy market Continue reading

Posted in Stem Cell Research | Comments Off on Global Cell Therapy Market Report 2020: Market is Expected to Decline from $7.31 Billion in 2019 to $7.2 Billion in 2020 at a CAGR of -1.54% -…

Mac Grory wins AHA/ASA 2020 Stroke Progress and Innovation Award – Duke Department of Neurology

Posted: Published on December 18th, 2020

Brian Mac Grory, MB BCh BAO, has won the American Heart Association/ American Stroke Association's 2020 Stroke Progress and Innovation Award (first place) for his research examining treatment for central retinal artery occlusion (CRAO), a rare type of stroke affecting the eye. The study performed by Mac Grory and colleagues found that clot-busting medications, if given within 4.5 hours after the eye stroke, improved the chances of vision recovery for patients with CRAO. This research, published July in Stroke, offers the best observational evidence for treating CRAO with thrombolysis that is currently available. Continue reading

Posted in Hyperbaric Medicine | Comments Off on Mac Grory wins AHA/ASA 2020 Stroke Progress and Innovation Award – Duke Department of Neurology

Cardiac ablation surgery: Types, risks, what to expect …

Posted: Published on December 18th, 2020

Cardiac ablation is a procedure that can help correct arrhythmia, which is a problem with the rhythm of a persons heartbeat. Continue reading

Posted in Cardiac Surgery | Comments Off on Cardiac ablation surgery: Types, risks, what to expect …

Bill to Expand Access to Certain Cardiac Procedures Passes the Senate – InsiderNJ

Posted: Published on December 18th, 2020

Bill to Expand Access to Certain Cardiac Procedures Passes the Senate TRENTON A bill that would seek to expand the number of facilities in New Jersey that are authorized to perform certain cardiac interventions, including diagnostic cardiac catheterization, primary angioplasty, and elective angioplasty services, passed the full Senate today. The bill would allow certain facilities outside cardiac surgery centers to perform these procedures, in an effort to provide greater access to high-quality cardiovascular care for patients throughout New Jersey. Continue reading

Posted in Cardiac Surgery | Comments Off on Bill to Expand Access to Certain Cardiac Procedures Passes the Senate – InsiderNJ

Elysium Health Announces Initiation of Phase II Clinical Trial at Mayo Clinic to Evaluate BASIS for Prevention of Acute Kidney Injury After Cardiac…

Posted: Published on December 18th, 2020

NEW YORK, Dec. 15, 2020 /PRNewswire/ --Elysium Health, Inc.,TM a life sciences company developing clinically validated health products based on aging research, today announced the initiation of a Phase II clinical trialat Mayo Clinic to evaluate the efficacy of BASISTM for the prevention of acute kidney injury (AKI) in patients that have undergone a cardiac surgery. The company previously announced the acceptance of an Investigational New Drug (IND) application by the Food and Drug Administration (FDA) to evaluate the efficacy of Basisfor the prevention of AKI Continue reading

Posted in Cardiac Surgery | Comments Off on Elysium Health Announces Initiation of Phase II Clinical Trial at Mayo Clinic to Evaluate BASIS for Prevention of Acute Kidney Injury After Cardiac…

Pensioner saved by cardiac surgery urges people not to avoid hospitals over COVID-19 fears – Sunday World

Posted: Published on December 18th, 2020

pensioner who had a life-saving mini defibrillator which can shock his heart into a normal beating rhythm - in what is believed to be the first procedure of its kind in a public hospital in Munster - has urged people not to avoid hospital appointments or planned surgeries over fears about COVID-19. Joseph ONeill, 74, from Moyasta, County Clare, received a subcutaneous ICD, cardioverter-defibrillator, at the Cath lab, University Hospital Limerick, last October. Mr ONeill suffered a mild heart attack in 2010 and it was recommended by doctors that he receive a different type of ICD device the kind where the wires travel along the veins and up to the heart which is traditionally used in heart attack patients. Continue reading

Posted in Cardiac Surgery | Comments Off on Pensioner saved by cardiac surgery urges people not to avoid hospitals over COVID-19 fears – Sunday World

PolyPid Initiates SHIELD II: Second Phase 3 Clinical Trial of D-PLEX for the Prevention of Post-Abdominal Surgery Incisional Infections -…

Posted: Published on December 18th, 2020

December 16, 2020 07:00 ET | Source: PolyPid Ltd. Enrollment in SHIELD I, the First Phase 3 Clinical Trial Continues to Progress, with Top-line Data Anticipated in Second Half of 2021 PETAH TIKVA, Israel, Dec. 16, 2020 (GLOBE NEWSWIRE) -- PolyPid Ltd Continue reading

Posted in Cardiac Surgery | Comments Off on PolyPid Initiates SHIELD II: Second Phase 3 Clinical Trial of D-PLEX for the Prevention of Post-Abdominal Surgery Incisional Infections -…

Coyle exits Medtronic to run iRhythm as diabetes lead Salmon takes over cardiovascular unit – FierceBiotech

Posted: Published on December 18th, 2020

Medtronic is shifting its C-suite after its cardiovascular portfolio lead and 11-year veteran Mike Coyle jumps ship at year-end to run wearable electrocardiogram maker iRhythm Technologies. He will be replaced Jan. Continue reading

Posted in Cardiac Surgery | Comments Off on Coyle exits Medtronic to run iRhythm as diabetes lead Salmon takes over cardiovascular unit – FierceBiotech

PM to open Peshawar Institute of Cardiology today – The News International

Posted: Published on December 18th, 2020

PESHAWAR: Its a dream come true for the people of Khyber Pakhtunkhwa as the long-delayed Peshawar Institute of Cardiology (PIC) is ready and Prime Minister Imran Khan will formally open it for patients today. Continue reading

Posted in Cardiac Surgery | Comments Off on PM to open Peshawar Institute of Cardiology today – The News International

Page 445«..1020..444445446447..450460..»